# Abiomed, Inc. – FDA Inspection, Aug 5, 2025

Source: https://www.keypedia.com/records/fda_inspections/abiomed-inc/398d847d-0cad-45aa-a294-fe023d6384fe
Source feed: FDA_Inspections

> FDA inspection 1234317 of Abiomed, Inc., August 05, 2025. Classification: Official Action Indicated (OAI). 4 citations under 21 CFR parts 803, 806 and 820. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1234317
- Company Name: Abiomed, Inc.
- Inspection Date: 2025-08-05
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Compliance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: New England District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1202491 - 2023-04-13](https://www.keypedia.com/records/fda_inspections/abiomed-inc/fcd3c682-3568-4f99-b9fd-b1b85a1ab600)
- FDA Inspection 1131459 - 2020-10-06
- FDA Inspection 1021587 - 2017-07-27
- FDA Inspection 964416 - 2016-03-25
- FDA Inspection 899479 - 2014-10-09

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/nabil-nakhoul/d676e9c9-566c-4e59-84e8-1dc474e4e48d)

Company: https://www.keypedia.com/companies/abiomed-inc/bf75e76c-c813-4c91-81e2-a86e5707a511

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144